ProShare Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Sell |
44,052
-6,073
| -12% | -$68.4K | ﹤0.01% | 1136 |
|
|
2025
Q1 | $506K | Sell |
50,125
-4,459
| -8% | -$45K | ﹤0.01% | 1091 |
|
|
2024
Q4 | $646K | Sell |
54,584
-8,136
| -13% | -$96.2K | ﹤0.01% | 1128 |
|
|
2024
Q3 | $724K | Buy |
62,720
+1,138
| +2% | +$13.1K | ﹤0.01% | 928 |
|
|
2024
Q2 | $651K | Buy |
61,582
+5,108
| +9% | +$54K | ﹤0.01% | 858 |
|
|
2024
Q1 | $595K | Buy |
56,474
+5,108
| +10% | +$53.8K | ﹤0.01% | 985 |
|
|
2023
Q4 | $577K | Buy |
51,366
+914
| +2% | +$10.3K | ﹤0.01% | 961 |
|
|
2023
Q3 | $589K | Buy |
50,452
+1,379
| +3% | +$16.1K | ﹤0.01% | 857 |
|
|
2023
Q2 | $495K | Sell |
49,073
-3,507
| -7% | -$35.4K | ﹤0.01% | 962 |
|
|
2023
Q1 | $388K | Sell |
52,580
-7,416
| -12% | -$54.7K | ﹤0.01% | 1047 |
|
|
2022
Q4 | $479K | Buy |
+59,996
| New | +$479K | ﹤0.01% | 982 |
|